For years, the globe has seen a bunch of digital diabetes care providers scrambling to churn out myriads of new gizmos under the banner of telehealth trends, but few could cut a striking, daring figure like Dnurse technology by coming up with a new set of digital diabetes care philosophy and a burgeoning brand.
Since its inception in June 2013, Dnurse Technology, invested by Sinocare and Innovation Works and SAIF, has been expanding its already-won stature as China’s first innovative mobile medical company to revolutionize traditional diabetes management wisdom. The enterprising company, however, has never forgotten why it started – to make its diabetes management services more technology-enabled, cost-effective, simple-to-use and patient-centered
With a view to allure more customers and stakeholders globally, Dnurse technology has it all: technological prowess, value-driven strategy, massive data trove and an eye-catching brand. The company – pioneering, responsible and determined – has occupied the number one slot among China’s digital diabetes care service providers. Not only is it the largest platform for diabetic patients in China, it’s also the No.1 smart glucometer manufacturer in China and India.
The Dnurse technology brand represents China’s digital diabetes management solutions at its best, and thus it’s no wonder that the company is quickening its pace to go international.
Deep inside the Dnurse technology brand, high-tech innovation is the overriding theme. In a nod to the fact that breakout technologies materialize from an innovative, sustainable formula, Dnurse technology has made it a business philosophy that “digital therapeutics (DTx) equates with device + data + decision (3D).” First off, true to its “3D philosophy”, the tech-savvy company has come on stream a wide selection of smart diabetes care devices, ranging from glucose meter to insulin dosage tracker, to make its diabetes management service more simple, safe and efficient.
Next up, with a broad user base of 1.6 million at home and abroad, Dnurse can get first dibs on leveraging a wealth of user data beamed from its smart gadgets, to produce professional, varied diabetes management solutions. From APP MAU and user retention, to HbA1c change trend and blood glucose normal rate 59%, a string of metrics would be factored into by the Dnurse App for augmenting management outcomes and enhancing patient compliance.
Most impressive is Dnurse’s powerful AI decision system – Intelligent Decision Support System (IDSS), which holds the key to keeping the Dnurse App ecosystem up and running. The system boasts a whopping more than 6,000 scenarios for diabetes management. Enabled by Baidu AI Accelerator and Microsoft Accelerator, the system is a perfect fit for WellDoc (Patient Coach, Expert System, Decision Support) and Livongo Health (Algorithm rule engine).
Aside from its array of high-tech innovations, the high-profile Dnurse brand is also underpinned by the company’s increasingly widening “friend circle” in China and beyond: renowned blood glucose monitoring system manufacturers, communication giants, top-rank hospitals, professional institutions and leading insurers. Their full backing fit Dnurse to provide a complete solution for all the daily needs of diabetics, ranging from patient online referral and online prescription to drug or insurance purchase services.
Never is a digital diabetes management provider of broader vision than this of Dnurse. It is fully aware that a holistic brand must focus on wider benefits beyond how well its solutions work to achieve better outcomes for diabetics and other stakeholders such as insurers and taxpayers. With substantial achievements in ramping up user engagement and retention, Dnurse has engaged a broader customer base on a global scale. On top of that, it also helped such pharmaceutical enterprises as Novo Nordisk and Sanofi to condition large amounts of patients to use their medicines in the long run.
Whoever overtakes will feel the headwind, and whoever leads the way will bear responsibility. Dnurse holds that if it leads the way in creating customer and shareholder value, great rewards will never be late. A rosier prospect for more patients and shareholders – the people-first, value-driven growth that Dnurse builds its increasingly multinational brand around – seemed to be within reach.
For more information, please access: https://www.dnurse.com/v2/en
Media Contact
Company Name: Dnurse Technology Co., Limited
Contact Person: Cindy Zhang
Email: Send Email
Country: China
Website: www.dnurse.com